Preview

Journal Biomed

Advanced search

Passive Avoidance in Adult and Middle-Aged Male C57BL/6 Mice after Intranasal α-Synuclein Administration

https://doi.org/10.33647/2074-5982-21-4-143-147

Abstract

A comparative study of the effects of α-synuclein species (monomers, oligomers or fibrils alone or in combination) administered intranasally for 14 days on passive avoidance in adult (3–7 months) and middle-aged (10–13 months) male C57BL/6 mice was conducted. Middle-aged mice treated with a solution of α-synuclein fibrils and oligomers were found to have a reduced latency to entry in the dark compartment during acquisition phase compared to controls (р<0.05). None of the experimental groups showed any impairment in long-term memory 24 h after training. The data obtained can be used in modeling human neurodegenerative diseases in animals.

About the Authors

O. A. Solovieva
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies
Russian Federation

Olga A. Solovieva

125315, Moscow, Baltiyskaya Str., 8



N. P. Mikhaylova
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies
Russian Federation

Nataliya P. Mikhaylova

125315, Moscow, Baltiyskaya Str., 8



M. A. Gruden
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies
Russian Federation

Marina А. Gruden, Cand. Sci. (Chem.)

125315, Moscow, Baltiyskaya Str., 8



V. V. Sherstnev
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies
Russian Federation

Vladimir V. Sherstnev, Dr. Sci. (Med.), Prof.

125315, Moscow, Baltiyskaya Str., 8



Z. I. Storozheva
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies
Russian Federation

Zinaida I. Storozheva, Dr. Sci. (Biol.)

125315, Moscow, Baltiyskaya Str., 8



References

1. Solovieva O.A., Gruden M.A., Kalinin I.A., Ratmirov A.M., Sherstnev V.V. Vliyanie kompozicionnoj smesi nativnoj i oligomernoj form belka α-sinukleina pri intranazal'nom vvedenii na povedenie stareyushchih myshej [Effect of a composite mixture of native and oligomeric forms of the α-synuclein protein upon intranasal administration on aging mouse behavior]. Pathogenesis. 2018;16(4):51–57. (In Russian)]. DOI: 10.25557/2310-0435.2018.04.51-57.

2. Alwani A., Maziarz K., Burda G., Jankowska-Kiełtyka M., Roman A., Łyszczarz G., Er S., Barut J., Barczyk-Woźnicka O., Pyza E., Kreiner G., Nalepa I., Chmielarz P. Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson's disease model. Pharmacological Reports. 2023;75(6):1474–1487. DOI: 10.1007/s43440-023-00530-z.

3. Carta A.R., Boi L., Pisanu A., Palmas M.F., Carboni E., De Simone A. Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species. J. of Neuroscience Methods. 2020;338:108685. DOI: 10.1016/j.jneumeth.2020.108685.

4. Gruden M.A., Davidova T.V., Yanamandra K., Kucheryanu V.G., Morozova-Roche L.A., Sherstnev V.V., Sewell R.D. Nasal inoculation with α-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine. Behavioural Brain Research. 2013;15(243):205–212. DOI: 10.1016/j.bbr.2013.01.011.

5. Hasegawa M., Nonaka T., Masuda-Suzukake M. α-Synuclein: experimental pathology. Cold Spring Harbor Perspectives in Medicine. 2016;6(9):a024273. DOI: 10.1101/cshperspect.a024273.

6. Lai T.T., Gericke B., Feja M., Conoscenti M., Zelikowsky M., Richter F. Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies. NPJ Parkinsons Disease. 2023:22;9(1):97. DOI: 10.1038/s41531-023-00547-4.


Review

For citations:


Solovieva O.A., Mikhaylova N.P., Gruden M.A., Sherstnev V.V., Storozheva Z.I. Passive Avoidance in Adult and Middle-Aged Male C57BL/6 Mice after Intranasal α-Synuclein Administration. Journal Biomed. 2025;21(4):143-147. (In Russ.) https://doi.org/10.33647/2074-5982-21-4-143-147

Views: 8


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-5982 (Print)
ISSN 2713-0428 (Online)